Evidence map›Paper›PMID 32997169›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2020

MetFID: artificial neural network-based compound fingerprint prediction for metabolite annotation.

Ziling Fan, Amber Alley, Kian Ghaffari, Habtom W Ressom

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. MIST-CF: Chemical Formula Inference from Tandem Mass Spectra.Journal of chemical information and modeling · 2024
    Article
  15. Natural Products Dereplication: Databases and Analytical Methods.Progress in the chemistry of organic natural products · 2024
    Review
  16. Article
  17. Article
  18. Deep Learning Based Metabolite Annotation.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ziling FanDepartment of Biochemistry and Molecular & Cellular Biology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Amber AlleyDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Suite 173, Building D, 4000 Reservoir Road NW, Washington, DC, 20057, USA.
Kian GhaffariDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Suite 173, Building D, 4000 Reservoir Road NW, Washington, DC, 20057, USA.
Habtom W RessomDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Suite 173, Building D, 4000 Reservoir Road NW, Washington, DC, 20057, USA. hwr@georgetown.edu.ORCID 0000-0001-9296-2132

Funding

Analysis of Racial Disparities in HCC by Systems MetabolomicsU01CA185188 · NCI · GEORGETOWN UNIVERSITY · PI RESSOM, HABTOM W · 2015 to 2019
$1.7M
Systems Metabolomics for HCC Biomarker DiscoveryR01GM123766 · NIGMS · GEORGETOWN UNIVERSITY · PI RESSOM, HABTOM W · 2017 to 2021
$1.5M
NCI NIH HHS U01 CA185188NIGMS NIH HHS R01 GM123766
6 · The paper itself

Abstract

introductionMetabolite annotation is a critical and challenging step in mass spectrometry-based metabolomic profiling. In a typical untargeted MS/MS-based metabolomic study, experimental MS/MS spectra are matched against those in spectral libraries for metabolite annotation. Yet, existing spectral libraries comprise merely a marginal percentage of known compounds.

objectiveThe objective is to develop a method that helps rank putative metabolite IDs for analytes whose reference MS/MS spectra are not present in spectral libraries.

methodsWe introduce MetFID, which uses an artificial neural network (ANN) trained for predicting molecular fingerprints based on experimental MS/MS data. To narrow the search space, MetFID retrieves candidates from metabolite databases using molecular formula or m/z value of the precursor ions of the analytes. The candidate whose fingerprint is most analogous to the predicted fingerprint is used for metabolite annotation. A comprehensive evaluation was performed by training MetFID using MS/MS spectra from the MoNA repository and NIST library and by testing with structure-disjoint MS/MS spectra from the NIST library, the CASMI 2016 dataset, and in-house MS/MS data from a cancer biomarker discovery study.

resultsWe observed that training separate models for distinct ranges of collision energies enhanced model performance compared to a single model that covers a wide range of collision energies. Using MetaboQuest to retrieve candidates, MetFID prioritized the correct putative ID in the first place rank for about 50% of the testing cases. Through the independent testing dataset, we demonstrated that MetFID has the potential to improve the accuracy of ranking putative metabolite IDs by more than 5% compared to other tools such as ChemDistiller, CSI:FingerID, and MetFrag.

conclusionMetFID offers a promising opportunity to enhance the accuracy of metabolite annotation by using ANN for molecular fingerprint prediction.

Indexed as

AlgorithmsDatabases, FactualHumansMetabolomicsNeural Networks, ComputerReference StandardsReference ValuesSoftwareSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryArtificial neural networkMetabolite identificationMetabolomicsMolecular fingerprint

Identifiers

PMID32997169
PMCPMC9547616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.